After the U.S. Food and Drug Administration’s (FDA) approved Merck’s HPV-9 Gardasil vaccine for use in adults age 27 to 45 in 2018, the Centers for Disease Control’s (CDC) Advisory Committee on Immunization Practices (ACIP) of the Department of Health and Human Services (HHS) is evaluating whether to expand their current HPV vaccine recommendation to include this new age group. ACIP’s current recommendation is that boys and girls ages 9 through 15 should get two-doses of HPV-9. The “catch-up” vaccine schedule is a three- dose series for females above age 15 through age 27 and males above 15 years of age to 21 years of age, if not previously vaccinated with HPV vaccine. Should ACIP expand their recommendations for use of HPV-9 vaccine in the newly approved age group, the CDC won’t be alone in the push to increase the use of the HPV vaccine by children and adults in the U.S. During the September meeting of the National Vaccine Advisory Committee (NVAC), a federal advisory committee that makes recommendations to the National Vaccine Program Office (NVPO), the HHS Assistant Secretary ADM Brett Giroir M.D. emphasized that HHS supported the NVAC’s HPV vaccine recommendations published in June 2018. Dr. Giroir stated that increasing HPV vaccination in America would be a focus for HHS in 2019. The federal government’s focus on increasing the use recommendations for the HPV vaccine may result in a renewed effort by state legislators to introduce legislation in many states to mandate HPV vaccine for school entry.
French Cancer Surgeon: Statistics Show HPV Gardasil Vaccine Linked to Increased Cervical Cancer Rates After Years of Decline Due to Pap Smears
It takes a long time to affirm that a preventive action really protects. But the failure of this supposed protection can sometimes be very quickly obvious. To prove that the Titanic was truly unsinkable would have required decades of navigation on the most dangerous seas of the world. Demonstrating that it wasn’t, took only a few hours … This » Titanic » demonstration is unfortunately reproduced by the Gardasil vaccination. Evidence that vaccination increases the risk of invasive cancer can be rapid, if the vaccine changes the natural history of cancer by accelerating it. The analysis of trends in the incidence of invasive cervical cancer published in official statistics (registers) was studied in the first and most fully vaccinated countries (Australia, Great Britain, Sweden and Norway). In all countries that achieved high HPV vaccination coverage, official cancer registries show an increase in the incidence of invasive cervical cancer. These paradoxical results plea for a rapid revision of recommendations and intensive research to explain this catastrophic issue.
CDC Lists Top Gardasil Vaccine “Champion” Doctors and Clinics in the U.S. Giving the Most HPV Vaccines
As we reported at the end of last month (December 2018), our #1 topic on Health Impact News in terms of readership is the Gardasil vaccine scandal, which you will almost never read about in the U.S. corporate-sponsored "mainstream" media. Our top 2 stories in 2018 were about the Gardasil vaccine, and we published many other articles about Merck's HPV vaccine Gardasil, the only HPV vaccine licensed for sale in the U.S., including news reports about how they are expanding their market by going into China, and obtaining FDA approval to expand the vaccine to older adults. These efforts are netting billions of dollars in new wealth for Merck. And Merck is apparently not expanding their market alone. They are doing it with help from the U.S. government, which also owns patents and earns revenue from the sale of the vaccine. The U.S. Centers for Disease Control and Prevention (CDC) just recently promoted the top doctors and clinics in the U.S. giving out the most Gardasil vaccines as "Champions" on their government-funded website. Since Gardasil is the #1 topic Health Impact News readers are concerned about, we figured you would be interested in knowing who these top doctors and clinics are in the U.S. giving out the most Gardasil vaccines, and we have republished the list of "Champions" in this article.
American Cancer Society Seeks $11 Billion to Pursue an 80% Gardasil Vaccination Rate Among U.S. Children
The American Cancer Society (ACS) has set an aggressive goal to achieve an 80 percent uptake rate among American children with two doses human papillomavirus (HPV) vaccine by 2026. To gain that coverage, 14 million more preteen children would need to complete the two-dose series, for a total of 57.62 million doses above and beyond the number of vaccinations given to date. HPV vaccine is one of the most expensive vaccines on the CDC recommended childhood vaccine schedule, costing a pricey $168 to $204 per dose, with Merck being the sole producer of HPV vaccine (Gardasil) in the U.S. Although U.S. health officials have continued to deny a causal connection, Japanese researchers have pointed out that the temporal association with post-Gardasil clinical symptoms such as “chronic regional pain syndrome, orthostatic intolerance, and/or cognitive dysfunction” suggests a causal relationship with the vaccine. Other health issues associated with HPV vaccination include nervous and immune system disorders such as postural orthostatic tachycardia syndrome (POTS), chronic fatigue syndrome, blood clots, acute respiratory failure and cardiac arrest. Also widely reported are menstrual abnormalities and premature ovarian failure. Using the MedAlerts search engine, as of April 30, 2018, the federal Vaccine Adverse Events Reporting System (VAERS) contained more than 58,992 reports of HPV vaccine reactions, hospitalizations, injuries and deaths including 430 related deaths, 794 hospitalizations, and 2,773 disabling conditions. Over 45 percent of the reported serious adverse events occurred in children and teens 12-17 years of age.
The following open letter to FDA Commissioner, Dr. Scott Gottlieb, calling for immediate investigations into many facets of the clinical trials for Gardasil sponsored by Merck was emailed today. Dear Dr. Gottlieb: This open letter, written on behalf of medical consumers around the world, is an urgent request for you to investigate potential malfeasance perpetrated by Merck during their clinical trials of Gardasil, the human papillomavirus vaccine that the FDA approved in June 2006. A new book, The HPV Vaccine on Trial: Seeking Justice for a Generation Betrayed, by Holland, Rosenberg, and Iorio, outlines at least four areas requiring the FDA’s urgent attention.
The HPV vaccine controversy has been raging since the FDA approved Gardasil in 2006 in virtually every country utilizing this new medical intervention. Dr. Stig Gerdes wrote this open letter to Danish Health authorities, the medical community, and local journalists hoping to shed some light on the very real consequences many Danish families were forced to deal with post-HPV vaccine use. Dr. Gerdes wrote: "The vaccine should be stopped immediately! There are so many unanswered questions that should be answered before we continue to vaccinate. With each injection, there is a risk of incapacitating a previously young strong human." Unfortunately, HPV vaccine stakeholders are still trying to deny the facts Dr. Gerdes was courageous enough to put in writing.
Parents, Scientists and Doctors from Around the World Gather to Discuss How to Handle Increasing HPV Vaccine Injuries
Earlier this year (2018) parents, scientists and doctors from all over the world gathered in Ireland at an IFICA conference to discuss the future of the HPV vaccine injured. The theme was "Working Together." The Ireland Government HSE (Health Service Executive) was invited to send representatives to attend, but they refused the opportunity to speak or listen to the world-renowned experts who attended. Instead, the HSE claims that the HPV vaccine is "100% safe" and labeled parents of HPV vaccine injured children as "Emotional Terrorists." As a result, victims suffering from Gardasil vaccine injuries in Ireland cannot get treatment, and must travel outside of the country to find medical help for their injuries.
Maryland parent Josh Mazer is a pro-vaccine parent. He has stated: "A properly administered, robust vaccine policy is instrumental in promoting the public welfare." (We disagree on this point.) However, there is one vaccine he does not promote, and after the local health department started promoting this vaccine to 12 and 13-year-old children without parental consent or knowledge, he decided to do some investigating behind this large public campaign of mass vaccination. The vaccine in question is Merck's HPV vaccine Gardasil, which is well-known to the readers of Health Impact News, but less so among the general public. Mazer was notified of the policy earlier this year (2018) by a "a career public school nurse" who told him that she was "being forced" to market Gardasil to 11 and 12-year-old kids at her school. Mazer decided to investigate why this was being presented as a "public health crisis," but none of the local health department officials gave him any useful facts or information to justify the mass HPV vaccine campaign. So he filed a Public Information Act request with the local government Prevention and Health Promotion Administration. He learned the state health department received $91.6 million just since 2012 from pharma funded non-profits to promote the HPV vaccine in Maryland. Bingo. Welcome to our world, Mr. Mazer.
In May 2018, Cochrane, the research organization that bills itself as the “international gold standard for high quality, trusted information,” released a flattering review of human papillomavirus (HPV) vaccines. The Cochrane review methodology involves pulling together data from clinical trials and reviewing the assembled evidence in what is supposed to be a standardized, systematic and neutral manner. In June, we reported that Cochrane’s sources of funding—agencies and foundations that are unwilling to brook any questions about vaccine safety—raise reasonable doubts about Cochrane’s conflicts of interest and ability to remain independent from its funders’ agendas. Now, researchers affiliated with one of Cochrane’s regional member centers (the Nordic Cochrane Centre) and with the Oxford-based Centre for Evidence Based Medicine (OCEBM) have come out with an exhaustive critique of Cochrane’s HPV review, published in BMJ Evidence-Based Medicine. Not mincing their words, the authors state: "We believe that the Cochrane [HPV vaccine] review does not meet the standards for Cochrane reviews or the needs of the citizens or healthcare providers that consult Cochrane reviews to make ‘Informed decisions,’ which…is part of Cochrane’s motto." The Nordic and OCEBM authors make many solid arguments about the Cochrane reviewers’ omissions and errors, including the reviewers’ inexplicable characterization of the higher death rate in the HPV group as “a chance occurrence.”
The UK government has recently announced that, by September 2019, boys aged 12 to 13 years will be given the human papillomavirus (HPV) vaccine, a vaccine that has been available to girls in the UK for the past ten years. There has been documented evidence that the HPV vaccine has caused more injuries than any other vaccination in history. Despite this evidence, however, the HPV vaccination has continued to be hailed a success by the pharmaceutical industry and governments alike. According to the MHRA, the adverse event reporting system in the UK, there have been a total of 9,119 reports of adverse reactions reported in the UK since the vaccine was launched in 2008. These reports equate to 23,882 different ailments and include a total of 8 deaths. The UK’s decision to include boys into the equation has alarmed many parents whose daughters have already been injured by the vaccine.